disease. Of the 141 patients, 37 (26%) presented with disease progression at the first detection (median level 18%); the other 104 (74%) presented with MRD (median level 0.3%), 86 of them (83%) were detected within the first 90 days post-SCT (early post-SCT MRD). A total 42 of 136 (31%) patients with pre-SCT MRD had subsequent progression as compared to 48 of 310 (15%) patients without pre-SCT MRD (p<0.01); 39 of 86 (45%) patients with early post-SCT MRD progressed at a median interval 41 days from the first MRD detection, whereas 20 of 309 (6.5%) patients progressed without early post-SCT MRD (p<0.01). Among the 309 patients, 4 of 59 (6.8%) with pre-SCT MRD had subsequently progressed versus 16 of 251 (6.4%) patients without pre-SCT MRD (p=0.77). Conclusions: Peri-transplant MRD detected by MFC is a significant risk factor for post-SCT disease progression that is likely associated with clinical relapse. The significance of pre-SCT MRD diminishes when early post-SCT MRD is taken into consideration, suggesting that post-SCT MRD may be a stronger predictor of relapse than pre-SCT MRD.
diagnosis more frequently in patients 35-year-old or younger than in patients older than 35-year-old, although the difference was not statistically significant (p=0.288). Microbiological tests confirmed the pathological results and provided a specific etiologic diagnosis in 77%(14/18) of the diagnosed cases. Conclusions: A simplified MIA technique allows obtaining adequate material for histological and microbiological analyses from body fluids and major organs. This procedure could greatly improve the determination of causes of death related to infections diseases in developing countries. This project is funded by the Bill & Melinda Gates Foundation (Global Health grant number OPP1067522) and by Spain's Instituto de Salud Carlos III (FIS, PI12/00757).
Utility of Reflexive Mycobacterial and Fungal Culture on Residual Frozen Section Tissue With Granuloma
Bella Goyal, Danielle Carpenter, Carey-Ann Burnham, Hanh-Tam Tran, Omar Ghanem. Washington University School of Medicine, St. Louis, MO; Union Memorial Hospital, Baltimore, MD; Medstar Union Memorial Hospital, Silver Spring, MD. Background: Culture-based identification of mycobacteria and fungi is the gold standard for species level identification. Although this method is slow, it is imperative to guide antimicrobial therapy. It is not uncommon that tissue demonstrating granuloma(s) microscopically in surgical specimens is entirely formalin fixed and not submitted for culture. Our objective was to evaluate a protocol whereby if granuloma was detected on frozen section, specimens were referred by pathology for mycobacterial and fungal culture. Design: This was a retrospective study evaluating surgical specimens with granuloma(s) present on frozen section examination over 2 years at a large academic medical center. Pathology results of AFB and GMS special stains were compared to culture results when available. Results: 233 surgical specimens with granuloma(s) present on frozen section examination were identified. 83 (36%) specimens were sent for culture: 62 by clinicians, 16 by pathologists, and 5 by both. Of those specimens sent for culture, 63 (76%) had corresponding GMS or AFB staining where organisms were identified in 24 specimens (16 fungi consistent with Histoplasma, 1 fungus consistent with Blastomyces, 1 other fungus, and 6 acid-fast bacilli). By culture, a species level identification was possible in 4 of 6 specimens (2 M. avium-intracellulare complex, 1 M. kansasii, 1 M. tuberculosis complex) which stained positive for AFB. In 13 specimens with fungi detected via GMS staining, no organisms were recovered in culture.
Conclusions:
In clinical specimens, culture of frozen tissue permits improved species level identification of AFB, but imparts minimal increased yield for fungal identification. The improved species level mycobacterial identification as a result of reflex culture of specimens with granuloma is an important quality assurance initiative for optimal patient therapy and infection control measures. Nuria Guimera, Maria Jose Fernandez Nestosa, Diego Fernando Sanchez, Elsa Velazquez, David Jenkins, Antonio Cubilla, Wim Quint . DDL Diagnostic Laboratory, Rijswijk, Netherlands; Universidad Nacional de Asunción, Asunción, Paraguay; Instituto de Patologia e Investigacion, Asunción, Paraguay; Miraca Life Sciences, Boston, MA; Tufts University, Boston, MA. Background: In many patients with penile neoplasia there are multiple histologically different lesions. Precise HPV attribution is needed to understand the role of HPV types in benign, premalignant and malignant lesions. The purpose of this study was to investigate presence of HPV types in each lesion by whole tissue section (WTS) and LCM-PCR of HPV+ specimens. Design: Eighty six paraffin blocks were sectioned by the sandwich technique for histological and PCR analysis. Multiple LCM-PCR samples were taken from individual lesions from 51 patients. Categories defined by consensus of 3 pathologists with final review after disclosure of HPV results (Table 1) . HPV analysis on WTS and LCM selected regions were performed by SPF 10-DEIA-LIPA 25 (version 1). DNA quality of all HPV negative cases was confirmed by RNaseP/PhHV qPCR. Design: Two autopsy cases with A/H1N1pdm09-ARDS were examined. The FFPE samples were taken from several parts of lungs, including at least one section from each lobe. All samples were analyzed by three methods: H&E stain for histological findings of DAD severity, immunohistochemistry and in situ hybridization for the distribution of A/H1N1pdm09, and real time RT-PCR of cytokine/chemokine mRNA for the immunological responses. Results: Both cases died on day eight post onset of the disease. There were some similar findings between them. Histological analysis showed exudative phase of DAD and there were variation in cytokine/chemokine expressions among different parts of lungs. The first case showed a significant variation in the DAD severity in histological analysis although viral antigen was detected broadly within the lung tissue. The second case showed homogenous DAD appearance but there was only a localized distribution of viral antigen in the lower lobe of lungs. Overall, there seems to be correlations among the DAD severity, viral distribution and local cytokine/chemokine expression levels in the lung. Conclusions: Unlike seasonal influenza, A/H1N1pdm09 infection can cause ARDS. We found correlations among the DAD severity, viral distribution and local cytokine/ chemokine expression levels in the autopsied lung with A/H1N1pdm09-ARDS. Our data supports the hypothesis that local and heterogeneous inflammatory response is the key to understand the underlying pathogenesis of ARDS induced by viral infection.
HPV Attribution in Non Cancerous, Precancerous and Invasive Penile Lesions: A Laser Capture Microdissection (LCM)-PCR Study

Results:
The Presence and Expression of AmpC-Type Beta-Lactamases May Lead To False Identification of Ertapenem Resistant Enterobacteriaceae as a Result of the Lowered CLSI Breakpoints
Brie Kezlarian, Laura Favazza, Kimberly Morawski, Tejal Patel, Robert Tibbetts. Henry Ford Hospital, Detroit, MI. Background: The growing threat of multi-drug resistant microorganisms, in particular, carbapenem resistant Enterobaceriaceae (CRE) has emerged as a top concern plaguing modern medicine. With the relative paucity of new antimicrobial medications to combat this onslaught, judicial use of appropriate antimicrobial therapy is crucial. In 2012, the Clinical Laboratory Standards Institute (CLSI) lowered the definition of carbepenem resistance from ≥8.0 ug/ml to ³2.0 ug/ml. Bacteria which were once considered of intermediate resistance are now being classified as CRE, potentially forcing clinicians to escalate antimicrobial therapies. We sought to determine whether these bacteria in fact harbored a carbepenem resistance gene (KPC), typical of true CRE, or if they were rather AmpC carriers, with an additional non-specific resistance mechanism, such as porin mutation or efflux pump, atypical for true CRE.
Design: We prospectively collected organisms with minimum inhibitory concentrations (MICs) to ertapenem between £0.25 ug/ml to ≥64.0 ug/ml as identified by automated antimicrobial susceptibility testing (AST). Carbapenem resistant and susceptible isolates were also included as positive and negative controls. Background: The development of next generation sequencing (NGS) and associated target sequence enrichment technologies has enabled time and cost effective detection of clinically relevant molecular alterations in hundreds of genes using a single clinical assay, thus paving the path for personalized medicine. Although data generation is no longer the major hurdle, accurate and time-effective bioinformatic and statistical analysis, and biologically meaningful interpretation of the data remain challenging. Design: We created CGA (Clinical Genome Analytics), an automated data analysis pipeline that is implemented using Civet, an in-house engineered XML-based framework for building analytical pipelines for efficient multi-step data processing. Results: CGA includes capabilities for automatic scheduling of jobs, monitoring analysis runs, and automatically saving information about each run (including command line options, versions and standard output/error for each tool). It puts together 17 different tools, from quality control and alignment through local realignment around indels and base quality recalibration to calling SNPs, indels and CNVs, and finally assigning genomic annotations to these variants. CGA takes an average of 6 hr to process samples containing approximately 25M paired-end reads, and ensures high (> 99.4%) sensitivity and specificity for the detection of >= 5% frequency SNPs and indels (<= 50bp) and of copy number changes >= 6. Conclusions: CGA is an automated analysis pipeline that ensures accurate and sensitive detection and clinical annotation of mutations. It is currently being used as part of an NGS-based molecular diagnostic assay that detects actionable mutations in solid tumors in a CLIA-certified laboratory. It provides not only an accurate analysis of samples in a clinically acceptable short turn-around time, but also the ability to document quality metrics and information on all of the tools, their versions and options, and all reference genomes and databases used, which is key to ensure reproducibility and traceability in a clinical set-up.
Utility of Automated Bioinformatic Pipeline in the Analysis and Interpretation of SNP Microarrays in Neoplasia
Alka Chaubey, Steven Van Vooren, Barbara DuPont, Ravindra B Kolhe. Greenwood Genetic Center, Greenwood, SC; Cartagenia, Inc., Cambridge, MA; Georgia Regents University, Augusta, GA. Background: SNP microarrays are being widely used as a tool in a routine oncology diagnostic workflow. The main advantage is its ability to accurately identify the composition of derivative chromosomes & marker chromosomes commonly observed in clonal populations. One of the biggest challenges of interpreting oncology arrays is the lack of bioinformatics tools facilitating the analysis and interpretation of microarray data. Another major challenge is to rule out the common polymorphic genomic variants stored in databases such as DGV, as well as having the ability to tease out potentially relevant copy number variable (CNV) and Loss-Of-Heterozygosity (LOH) regions possibly contributing to the pathogenesis of neoplastic disorder. The aim of this study was to access and configure the utility of an automated bioinformatic pipeline in the analysis and interpretation of SNP Microarrays in neoplasia.
Design: For constitution SNP array's our lab has been using various automated bioinformatics pipelines for data analysis and reporting. For oncology SNP array data analysis and interpretation we collaborated with Cartagenia Inc. Aim is to create a different variant assessment and filtration strategies that can be established and automated for the analysis of SNP microarrays in various leukemias and the utility of the Bench platform in the identification of pathogenic changes. We selected array SNP array data from 42 cases of cytogenetically normal cases of CMML, Myelofibrosis and ALL and subjected to the customized bench. Results: Our studies have allowed us to establish specific filters for the determination of potentially significant copy number changes (like mosaic deletions and mosaic duplications). SNP microarrays also have the added advantage of identifying regions of LOH which play a very important role in the 2 hit hypothesis in somatic cancers. Our filtration allowed removing germline mutations, stored in databases such as DGV, as well as alignment of genomic variants with control populations or healthy tissue samples. We have also been able to establish an automated filtration and reporting pipeline that allows the identification and reporting of regions of LOH harboring important cancer genes such as CDKN2A and JAK2. Conclusions: We propose that an automated bioinformatic pipeline for the analysis and interpretation of neoplastic disorders will benefit the labs and oncologists ordering a high-resolution chromosomal microarray in a diagnostic setting.
Diagnostic and Educational Uses of Google Glass in Anatomic Pathology
Natalie Ciomek, Hongfa Zhu, Carlos Cordon-Cardo. The Icahn School of Medicine at Mount Sinai, New York, NY. Background: Google Glass is a wearable intelligent device permitting the capture and communication of photography and video via its hands-free, voice recognition capabilities. Multiple institutions are investigating the use of Glass technology in health care, most notably within surgical and internal medicine specialties. Glass utilization within pathology has been limited to very few reports. The first study investigated livestreaming of routine specimen dissection; another study described the acquisition and quality of still images in forensic autopsy findings. To date, no studies have applied the use of Glass-acquired data, specifically videos, for subsequent diagnostic and educational purposes in anatomic pathology. Design: Google Glass (Explorer edition) photography and videography was implemented as an adjunct to routine gross specimen documentation by hand-held digital photography during intraoperative consultations and/or routine permanent processing. Specimens included pulmonary, gynecologic, and gastrointestinal resections. The edited dissection videos were less than 40 seconds in length. Data was obtained, stored, and accessed in the same secure and HIPAA-compliant methodology currently in place for digital gross photography. Specimen photography and videography were evaluated in several clinical and educational capacities, including but not limited to consultations among residents and attendings, gross specimen review at the time of microscopic examination, pathology resident education, and inter-and intradepartmental conferences. Results: Glass technology obtained images and videos with quality comparable to those by digital photography but without disruption or increase in processing time to pre-existing grossing procedures. The use of Glass was described as more convenient and efficient than conventional photography. Dissection videos of complex resection specimens, beginning from their intact and fresh states to their final sectioning, were reported to be of greater diagnostic and educational utility than both photography and gross specimen review of the fixed and sectioned tissues. Conclusions: Glass has demonstrated clinical and educational value within anatomic pathology. The analysis of surgical specimens in pathology almost always requires specimens to become disrupted and altered in fixative following dissection. Maintaining quality photographic and video records of the intact and fresh specimens at the time of initial dissection is important for diagnoses and reporting, medical education, and potential error reduction. 
FISH Digital
